Hyaluronic Acid Market by Application (Osteoarthritis, Cosmetics, Pharmaceutical API, Ophthalmology, Others), by End-Use Industry (Personal Care Industry, Pharmaceutical Industry, Others), and by Region (North America, South America, Europe, Asia Pac
The Federal Circuit handed down an opinion last week that invalidated several asserted claims and found infringement under 35 U.S.C. § 271(e)(2) of the claims, while refusing to modify.
Hyaluronic Acid Market by Application (Osteoarthritis, Cosmetics, Pharmaceutical API, Ophthalmology, Others), by End-Use Industry (Personal Care Industry, Pharmaceutical Industry, Others), and by Region (North America, South America, Europe, Asia Pac
In a precedential opinion issued on April 11, 2024 in Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc., Nos. 22-2153, 23-1952, the U.S. Court of Appeals for the Federal.
In the United States District Court for the Northern District of West Virginia, Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc. have filed a lawsuit against Mylan Pharmaceuticals Inc.